ClinicalTrials.gg
RecruitingNCT06014203Updated Mar 29, 2024

Examination of Edema After Arthroscopic Shoulder Surgery

An observational study in Edema, Arthroscopy and Shoulder, sponsored by Gazi University. Recruiting at 1 site in Turkey. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-03-29.

Sponsored by Gazi University · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2024, 2 years 6 months ago, but the record still lists the study as recruiting.
  • Started Sep 2023; still recruiting 3 years 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 80 studies in Edema with a site in Turkey — 11 open to participants now, 15 under way, 1 of them phase 3. Edema · Turkey.

Planned enrollment
4th of 18
100 · median 62
Started
2023
with 11 others
Observational
18 of 80
4 open now
Primary completion
2024-04
later than 2 of 14 live
Registered
42nd of 80
by date
Lead sponsor
3 of 80
Gazi University

Among the 80 studies in Edema with a site in Turkey, this one is the 4th largest by planned enrollment of the 18 observational ones that give a count, is one of 12 that started in 2023, is one of 18 observational ones, reaches primary completion later than 2 of the 14 other live ones, and was the 42nd registered.

Edema

568 studies on the registry are indexed under Edema; 97 are open to participants now.

Browse Edema studies →

Open to participants now

11 of the 80 studies in Edema with a site in Turkey are open now. Recruiting first, the newest first:

5 more — sign in →

All 11 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 56 Edema studies recruiting now, 34 (61%) set no upper age limit and 16 (29%) stop at 75 or younger; 8 take children under 18; 4 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 80 studies in Edema with a site in Turkey, or all of them as a file.
02

Study summary

The investigators's aim is to examine trunk and upper extremity edema after arthroscopic rotator cuff repair and/or labrum repair surgeries. During surgery, the shoulder joint capsule is cut and the joint is entered arthroscopically. During this procedure, approximately 3-6 liters of saline fluid is injected into the joint, depending on the duration of the surgery. The given fluid accumulates out of the joint in relation to the duration of the surgery and the amount of fluid given. In this study, the investigators aim is to examine how much the extra-articular fluid collects under the skin of the upper extremity and trunk, and the change in the amount of fluid 24 hours after surgery. Examination of the amount of subcutaneous fluid may help to better understand the postoperative complications such as edema, carpal tunnel syndrome, compartment syndrome, myolysis, and dyspnea. How much edema the joint and surrounding structures are exposed to and its relationship with the duration of surgery can help to clinicians determine the safe discharge time.

03

Conditions studied

  • Edema
  • Arthroscopy
  • Shoulder

Browse trials for

Keywords

  • Edema
  • Shoulder arthroscopy
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients scheduled for arthroscopic shoulder surgery in Gazi University Hospital, Department of Orthopedics and Traumatology

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Arthroscopic shoulder surgery planned
  • 18-65 years old

Exclusion criteria

Exclusion Criteria:

  • Frozen/stiff shoulder
  • Metabolic and endocrine diseases
  • Dermatological pathologies
  • Hyperlaxity
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients undergoing shoulder arthroscopy surgery

    Patients who underwent arthroscopic shoulder surgery by a single surgeon at Gazi Hospital Department of Orthopedics and Traumatology (rotator cuff repair, slap, bankart repair)

    Diagnostic Test: Edema measurement

Interventions

  • Diagnostic testEdema measurement

    Subcutaneous fluid measurements will be made 3 times in total, before the surgery, immediately after the surgery and 24 hours after the surgery. Measurements will be made with the MoistureMeterD Compact local edema measuring device. Points to be measured: 1. Midpoint of the upper trapezius muscle 2. 5 cm distal to anterior acromion 3. 5cm distal to lateral acromion 4. 5cm distal to posterior acromion 5. 3cm medial to the axilla 6. Anterior cubital fossa 7. Carpal tunnel

06

What researchers measure

Primary outcomes

  1. Edema

    After the MoistureMeterD Compact local edema measuring device is placed perpendicular to the area to be measured, it will be held for 3 seconds and the percent moisture value will be recorded. 3 measurements will be made for each region. The average of the 3 measurements will be used in the statistical analysis.

    Time frame: 3 months

Secondary outcomes

  1. Surgery time

    The duration of each operation will be recorded in minutes by the surgeon performing the operation.

    Time frame: 3 months

  2. Amount of the saline

    The amount of saline fluid used in each operation will be recorded in liters by the surgeon performing the operation.

    Time frame: 3 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — There is not a plan to make IPD available.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2023 (actual). Primary completion is estimated for Apr 2024, 7 months after the start.

Of 76 non-industry observational studies under Edema, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 39. This study's planned 7 months is below that.

Counting every sponsor, half of 85 studies reached it within 23 months; a quarter within 7 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 21, 2023
First posted
Aug 28, 2023
StartActual
Sep 1, 2023
Primary completionEst.
Apr 30, 2024
CompletionEst.
May 10, 2024
Last update
Mar 29, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06014203
Lead sponsor
Gazi University
Responsible party
İnci Hazal Ayas (Principal Investigator, Gazi University) — Principal investigator
First posted
Aug 28, 2023
Start date
Sep 1, 2023
Primary completion
Apr 30, 2024 (estimated)
Completion
May 10, 2024 (estimated)
Last update
Mar 29, 2024

Study contacts

İnci H Ayas
Contact
inciayass@gmail.com
05071740342
Ulunay Kanatlı
study director · Gazi University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion